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Spondyloarthritis
AbstrAct
Recognition of axial spondyloarthritis (SpA) remains 
challenging, as no unique reference standard is available 
to ascertain diagnosis. imaging procedures have been 
used for long in the field, in particular pelvic radiography, 
to capture structural changes evocative of sacroiliitis, the 
key feature in SpA. The introduction of MRi of the sacroiliac 
joints (SiJs) has led to a major shift in recognition of 
the disorder. MRi has been shown to detect the initial 
inflammatory processes, in particular osteitis depicted 
by bone marrow oedema, even in patients having not yet 
developed structural lesions. in addition, MRi has revealed 
a previously under-recognised very early clinical phase 
of the disease where patients have symptomatic axial 
involvement, but no structural changes. However, what 
constitutes a ‘positive MRi’ in SpA remains controversial, 
since both sensitivity and specificity show limitations, 
and interpretation of MRi lesions in daily practice is 
critically dependent on the clinical context. There is 
growing evidence that integration of the assessment 
of structural changes on dedicated T1 weighted-
sequences on MRi may enhance diagnostic utility. The 
performance of MRi in detecting structural lesions in the 
SiJs may even be superior to traditional evaluation by 
pelvic radiography. These findings launched a debate on 
imaging in SpA, whether MRi, which is advancing early 
recognition of disease and shows superiority to detect 
structural changes, should replace traditional conventional 
radiography of the SiJs.
InTroduCTIon
The concept of non-radiographic axial 
spondyloarthritis
Diagnosis of spondyloarthritis (SpA) often 
remains challenging, especially in its axial 
form, when no objectively detectable sign of 
the disease can be observed by the consulting 
physician. Diagnosing an advanced axial or 
peripheral form of SpA in a patient referred 
for joint effusion, dactylitis or already anky-
losed spine usually does not raise major 
concerns, but discrimination between 
non-specific chronic low back pain and 
inflammatory back pain due to early axial 
SpA may prove more challenging. Recent 
advances in management of SpA have made 
diagnostic ascertainment crucial, since inno-
vative alternatives to nonsteroidal anti-inflam-
matory drugs (NSAIDs) have become avail-
able. Biological agents have proven major 
efficacy in axial SpA, which even in its early 
phase is associated with substantial impair-
ment of quality of life and high burden of 
disease.1 This switch of interest to early axial 
SpA in the past two decades was further 
promoted by the advent of advanced imaging 
modalities such as MRI to detect early sacro-
iliitis before radiographic structural damage 
appears, and by the hypothesis of a ‘window 
Key messages
What is already known about this subject?
 ► MRi of the sacroiliac joints (SiJs) is 
recognised as key imaging biomarker of axial 
spondyloarthritis (SpA), especially for recognition 
of emerging inflammation in the early phase of the 
disease.
What does this study add?
 ► what constitutes a positive MRi for axial 
SpA remains controversial due to limited sensitivity 
and specificity of the 'suggestive bone marrow 
oedema' lesions. The performance of pelvic 
radiography for the detection of structural lesions 
in the SiJs is increasingly called into question by 
recent data on limited reliability and sensitivity, 
while dedicated T1-weighted MRi sequences have 
shown superior ability in assessing structural 
changes.
How might this impact on clinical practice?
 ► Standardised and contextual evaluation of MRi of 
the SiJs, incorporating assessment of structural 
changes, may increase diagnostic utility. whether 
MRi might eventually even replace conventional 
radiography is a matter of debate.
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of opportunity’ that treatment initiated in early disease 
might modify long-term outcome.2 
Currently available criteria sets have, despite good 
global performances, undisputed limitations when 
applied in individual patients, and no unique disease-spe-
cific gold standard can be referred to in this context. 
These sets were developed to serve as classification rather 
than diagnostic criteria, although they are often used for 
disease recognition as well, as the same items are used in 
both settings.
The seminal importance of MRI in this context is its 
capability to reveal a hidden part of the disease, which 
could not be detected so far in patients with axial 
involvement without detectable structural radiographic 
features, but with signs or symptoms indicative of SpA. 
These patients can be classified as having ‘axial non-ra-
diographic spondyloarthritis (nr-axSpA)’ according to 
criteria developed by the Assessment of Spondyloarthritis 
International Society (ASAS), which encompass chronic 
back pain (usually inflammatory back pain), associated 
with an evocative context, in particular presence of 
the HLA B27 antigen and/or sacroiliitis as detected by 
MRI.3 An advantage of MRI of sacroiliac joints (SIJs) is 
superiority to detect early phases of the disease versus 
conventional radiography, which in most cases has 
delayed sensitivity by several years after symptom onset, 
and which can even remain normal in some patients.4 A 
patient can also be classified as having nr-axSpA in the 
absence of imaging abnormalities (including MRI), by 
the so-called ‘clinical arm’ of ASAS classification criteria 
of axial SpA, provided the susceptibility HLA B27 gene 
is present and at least two features suggestive of SpA 
are observed during diagnostic evaluation. Criticism 
about the classification criteria included concerns about 
limited specificity given the high background prevalence 
of chronic non-specific back pain which may result in 
false positive assignments.5 6
MRI features are also considered a predictive factor of 
therapeutic response to anti-tumor necrosis factor (TNF) 
agents in axial SpA. The presence of unequivocal inflam-
matory lesions on SIJ MRI in patients with axial SpA was 
associated with a positive clinical response to anti-TNF 
drugs.7 8 These data provided the basis for the decision 
of the European Medicine Agency to restrict approval 
for TNF treatment indication to patients ‘having either 
detectable inflammatory lesions on MRI or elevated C-reactive 
protein’.9
The radiographic mnY criteria derived from patients with 
ankylosing spondylitis
Evaluation of SIJ on pelvic X-rays according to the modi-
fied New York (mNY) criteria served for decades as 
the gold standard to ascertain a diagnosis of ankylosing 
spondylitis (AS) at a given time point. In this classifi-
cation system, patients are considered with AS if they 
report chronic inflammatory back pain and/or have 
limited mobility of lumbar spine or chest expansion, but 
the most discriminant element is the presence of either 
bilateral sclerosis or (limited) erosions, or at least unilat-
eral severe erosions, widening of joint space or ankylosis 
of SIJ on pelvic X-Ray.
Actually, the mNY criteria were derived from a 
cohort of 183 HLA-B27 positive patients with AS, their 
HLA-B27-positive or HLA-B27 negative first-degree rela-
tives, and population controls.10 Qualitative thresholds—
with inherent subjectivity—to discriminate five grades 
of structural SIJ damage are applied, which promote 
inter-reader variability. Reliability of radiographic mNY 
criteria is further impaired by the lack of standardised 
and validated definitions for the five radiographic lesion 
types described originally in the Atlas of Standard Radio-
graphs of Arthritis.11 There are limited data regarding 
radiographic SIJ lesion frequency and morphology in 
patients with mechanical back pain, in subjects with high 
physical activity, multiparous women, or regarding ‘back-
ground noise’ in healthy subjects. A primary back pain 
cohort from chiropractic practices in Canada showed 
degenerative SIJ changes in 35.2% of 142 women aged 
18–60 years, which may contribute to reader disagree-
ment in low grade sacroiliitis.12 Technical issues such as 
two-dimensional radiographic depiction of the complex 
three-dimensional joint anatomy or bowel structures 
superimposing the SIJ may also restrict reproducibility of 
SIJ evaluation on pelvic radiographs. In addition, features 
of radiographic sacroiliitis should not be applied in 
young subjects when pelvic growth plates are still open.13
How reliable are the radiographic mnY criteria in patients 
with early axial SpA?
Studies over the last three decades suggest that reliability 
of radiographic SIJ classification may depend on the 
frequency of subjects with already advanced radiographic 
joint damage. The higher the proportion of patients with 
AS in a given study sample, the better the concordance in 
radiographic SIJ classification. Substantial reliability with 
kappas (k)s of 0.66–0.69 between two trained rheumatol-
ogist readers was recorded in a study of 217 patients with 
AS who all met the mNY criteria.14 A cohort study about 
progression of radiographic sacroiliitis in axial SpA 
having 54.8% patients with AS showed moderate relia-
bility between two trained rheumatology readers at base-
line with a k value of 0.59.15 Agreement increased slightly 
to k of 0.67 at 2 years’ follow-up when additional 11.6% 
patients with  non-radiographic axial SpA had progressed 
to AS. On the other hand, a cohort study in patients with 
inflammatory back pain suggestive of axial SpA, where 
only 21.1%–26.6% showed obvious radiographic sacroili-
itis, showed k concordance for radiographic mNY criteria 
of 0.55 for central versus local radiologist and rheumatol-
ogist readings.16 Moreover, a report on an SpA inception 
cohort with just 15.7% patients with mNY criteria-posi-
tive back pain recorded only fair to, at best, moderate k 
reproducibility of 0.39 among seven radiology and rheu-
matology readers with varying experience in imaging 
in SpA.17 This study even suggested that erosion, which 
is widely regarded as a prototypical lesion indicating 
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radiographic sacroiliitis, may be the primary driver of 
discordant classification. A study from Turkey applying 
the radiographic mNY criteria in a cohort of patients with 
Behçet’s disease reported low k values for pretraining/
post-training agreement of 0.32/0.19, 0.32/0.36 and 
0.44/0.41 for three reader pairs (one radiologist and two 
rheumatologists), respectively.18
A Dutch report concluded that training may not alter 
agreement in evaluation of radiographic sacroiliitis:19 
Radiographic assessment of sacroiliitis by 100 rheumatol-
ogists and 23 radiologists showed only modest sensitivity 
and specificity and substantial intraobserver variation. 
Evaluation of the same image set after 3–6 months on 
individual training and workshops did not improve 
performance compared with the gold standard of scores 
by an expert panel of two rheumatologists, one epidemi-
ologist and one radiologist.
How reliable is SIJ MrI versus radiography in adult and 
juvenile patients with early axial SpA?
A comparison of both imaging modalities in a cohort of 
patients with  recent onset back pain clinically suspected 
to have early axial SpA highlighted only moderate agree-
ment (k 0.54) of radiographic SIJ evaluation by central 
rheumatologist and radiologist readers.16 Conversely, 
assessment of SIJ MRI according to the ASAS definition 
based on active inflammatory lesions showed substantial 
agreement among central readers with a k value of 0.73.20 
Moreover, even regarding structural lesions, a cross-sec-
tional study in 68 patients with AS and 44 with non-radio-
graphic axial SpA showed superior reliability in detection 
of the key lesion erosion on SIJ MRI (Κ 0.46 between two 
readers) than on pelvic radiographs (k 0.22).21 Superior 
performance of SIJ MRI over pelvic radiographs has also 
been reported in juvenile SpA.22 In a controlled retro-
spective cohort study of 26 patients with juvenile SpA, 
global assessment by SIJ MRI (k 0.80) was substantially 
more reliable compared with pelvic radiography (k 0.30).
Are the radiographic mnY criteria reliable to assess 
‘progression’ in patients with early axial SpA?
The limited reliability of the mNY criteria may contribute 
to substantial measurement error when assessing 
progression of radiographic sacroiliitis in patients with 
early SpA.23 Blinded evaluation of baseline and follow-up 
pelvic radiographs in a cohort of 449 patients with clini-
cally defined recent onset SpA showed progression over 
2 years from mNY criteria negative to positive in 4.9% of 
subjects, but vice versa also regression from mNY criteria 
positive to negative of comparable magnitude of 5.7%. A 
similar analysis from the ASAS cohort24 recruited from 
many centres worldwide yielded even more puzzling 
results when comparing radiographic mNY grading 
by local readers (radiologists or rheumatologists, not 
necessarily the same reader at baseline and follow-up) 
after a mean follow-up of 4.4 years: of 975 patients at 
baseline, 357 had paired sacroiliac radiographs avail-
able at follow-up,24 and progression from radiographic 
mNY criteria negative to positive was observed in 18.3% 
(54/295 patients), and regression from positive to nega-
tive in 58.1% (36/62 patients). A potential explanation is 
that discrimination of true progression of radiographic 
sacroiliitis from measurement error over a mean interval 
of 4.4 years is challenging, which is a call to evaluate alter-
native imaging modalities to capture progression of SIJ 
damage.24 Regarding the limited sensitivity of pelvic radi-
ography when applying mNY criteria, a higher, although 
still modest, rate of progression from ‘no AS’ to ‘AS’ 
has been reported when a cut-off of at least a change 
in one grade in at least one SIJ is applied, rather than a 
change from ‘not fulfilling mNY criteria’ to ‘fulfilment 
of radiographic criteria’.25 A cohort analysis on rates of 
radiographic sacroiliitis progression over 2 years in axial 
SpA reported 11.6% of patients transitioning from radi-
ographic mNY criteria negative to positive, while 2.6% 
switched back from positive to negative.15 Sacroiliac radi-
ographic progression over 5 years in an SpA inception 
cohort with evaluation according to the mNY criteria 
blinded to time order reported a small net progression 
rate in 5.1% of patients.25 Worsening by fulfilment of the 
radiographic criteria over time was observed in 5.8% of 
the patients, while a switch from radiographic to non-ra-
diographic classification was recorded in 0.7%. Net radio-
graphic progression was associated with inflammation on 
SIJ MRI assessed binarily as present or absent.
Limitations of MrI in axial SpA
Despite its superior reliability compared with radiography 
and its unanimously recognised relevance in the context 
of diagnostic assessment of a young patient referred for 
chronic back pain, MRI of SIJ has several limitations to 
take into account.
What constitutes a positive MrI in axial SpA?
First of all, although often regarded as an objective evalu-
ation in SpA, MRI remains an imaging investigation that 
needs appropriate interpretation to provide the clinician 
with relevant information, whether ‘appropriate’ inter-
pretation means ‘independent from’ or conversely ‘within 
a comprehensive clinical context’, needs further clarification. 
Indeed, the impressive specificity of MRI (97.3%) in a 
classification context as reported by the ASAS cohort 
aiming at developing the current classification criteria 
must be nuanced by the methodology that was applied. 
As no objective gold standard is available regarding the 
diagnosis of axial SpA, the final classification was made 
by experts in the field, after careful investigation of the 
patient including history, clinical signs, biological testing 
and MRI assessment. The latter information had a major 
impact on the expert’s final judgement, as it had led to a 
change in expert opinion in 21% of the patients.26 These 
criteria have been revisited after a mean follow-up of 4.4 
years in a subsample of the ASAS cohort that was designed 
to develop the criteria set in patients with chronic low 
back pain less than 45 years at symptoms onset. The posi-
tive predictive value of the criteria was very high (92.2%), 
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but the potential methodological limitation of partial 
‘circular reasoning’ needs to be taken into account when 
applying the criteria set in clinical routine.27
Another important limitation encountered in clin-
ical practice is the definition of a ‘positive MRI’ of SIJ. 
Interpretation by the radiologist and/or the rheumatol-
ogist is inherently subjective, and no objective reference 
standard could be defined in the development phase of 
the consensual criteria.26 Although it was stated in the 
original publication that only ‘inflammatory’ lesions, 
and especially bone marrow oedema/osteitis should be 
taken into account, no standardised definition of extent, 
location or intensity was provided. Paraphrasing the 
inflammatory lesion as being ‘highly suggestive of sacroiliitis 
associated with SpA’ remained the only anchor available to 
discriminate from mechanical back pain. Nevertheless, 
it was suggested that having one lesion on two consecu-
tive slices or at least two lesions on a single slice could be 
regarded as sufficient for a positive SIJ MRI suggestive of 
sacroiliitis, although these cut-offs have not been formally 
validated, which might have resulted in false-positive 
assignments due to mechanical strain, vascular signals or 
artefacts on SIJ MRI.
Actually, both daily clinical practice and data from 
recent research in the field indicate that interpretation 
of MRI of SIJ is not an easy task. The expected binary 
response ‘positive’ or ‘negative’ SIJ MRI must often 
be replaced by varying levels of confidence. Indeed, 
the presence, number and extension of bone marrow 
oedema features are very heterogeneous across patients, 
their anatomical location is of crucial relevance (but not 
always taken into account by rheumatologists or radiol-
ogists), and the agreement for different lesion types 
can vary, even among trained and calibrated assessors.16 
These discrepancies may translate into misclassifica-
tion in both directions, with missed patients as well as 
excess diagnoses of SpA, in a small, but not negligible 
proportion of patients. On the background of the high 
prevalence of chronic back pain in the general popula-
tion, discordant classification might result in substantial 
numbers of inappropriate therapeutic decisions.
Limited specificity
Presence of lesions on SIJ MRI indicative of SpA is rather 
common in patients with non-specific back pain, and 
is even possible in healthy subjects, which raises concerns 
about specificity of bone marrow oedema as detected 
by SIJ MRI. Multiple studies have reported that a size-
able proportion of non-SpA patients with back pain and 
healthy control subjects can be erroneously classified as 
having active sacroiliitis based on MRI scanning. Already 
in 2009, Marzo-Ortega et al reported a high prevalence 
of bone marrow oedema in up to 6/22 (27%) in a 
control sample of healthy volunteers and patients with 
mechanical back pain.28 A similar proportion of MRI 
lesions suggestive of SpA was recorded in MRI assess-
ment of the spine. A study evaluating whole-body MRI in 
patients with SpA and healthy control subjects observed 
presence of bone marrow oedema in vertebral corners 
of 26% of healthy volunteers, as concordantly reported 
by a least two readers.29 In another study comparing 
the prevalence of various lesion types on MRI scans of 
patients with AS, recent onset inflammatory back pain, 
non-specific back pain and healthy subjects, presence of 
bone marrow oedema in SIJ meeting the ASAS criteria 
was confirmed concordantly by at least two of five inde-
pendent readers in 64/75 (85.3%) of patients with AS, 
18/27 (66.7%) of patients with inflammatory back pain, 
in 23.1% of patients with non-specific back pain and 
6.8% of healthy subjects.30 As observed in this study, 
specificity will expectedly decrease when patients from 
the control group have a pretest condition evocative 
of the final disease, which is the prerequisite of a study 
aiming at developing diagnostic criteria, whereas the 
development of classification criteria may use healthy 
subjects as controls, and thus result in higher specificity.31 
Other conditions like Diffuse Idiopathic Skeletal Hyper-
ostosis (DISH) are associated with MRI features resem-
bling SpA-associated sacroiliitis, although the MRI of SIJ 
remained more specific than the MRI of the spine in this 
systematic assessment of patients diagnosed with DISH.32 
An evaluation of SIJ MRI in athletes showed bone marrow 
oedema compatible with ASAS standards as concord-
antly reported by at least two of three trained readers in 
30%–35% of hobby runners and 41% of elite ice-hockey 
players, respectively.33 A topographical analysis showed 
an interesting clustering of these non-inflammatory bone 
marrow lesions in the posterior lower ilium, followed in 
frequency by the anterior upper sacrum. These results 
are consistent with the bone marrow oedema findings 
in SIJ of Belgian military recruits, who met the ASAS 
criteria in 23% and 36% before and 6 weeks after inten-
sive physical training, respectively.34 A generic limitation 
to all proposals about positive SIJ MRI in SpA is the age 
range of 18 years to 45 years or 50 years of enrolled study 
subjects. This fact precludes extrapolation to subjects 
over age 50 years due to a lack of data.
Limited sensitivity
MRI lesions in patients with SpA may fluctuate, pointing 
out the limited sensitivity of MRI for diagnostic purposes 
in case it would be used as the sole evaluation tool. Two 
studies exploring diagnostic utility of SIJ MRI by two 
different gold standards consistently showed that sensi-
tivity in the clinical setting of suspected early SpA reached, 
at best, 50%. In a first study testing the performance of SIJ 
MRI in 187 adult subjects aged less than 45 years (75 with 
AS, 27 with inflammatory back pain but no radiographic 
changes on pelvic X-rays, 26 with non-specific back pain 
and 59 healthy controls), global assessment of SIJ MRI 
yielded a mean sensitivity over five readers of 51% using 
physician expert opinion based on clinical, laboratory 
and radiographic examination as the independent gold 
standard.30 Another study applied histology on SIJ biop-
sies compatible with inflammation as reference standard 
in 109 patients clinically suspected to have early axial SpA, 
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but who showed no or only minimal radiographic lesions 
of SIJ.35 In 77 patients, in whom also SIJ MRI was available, 
23 subjects showed MRI evidence of sacroiliitis defined 
by bone marrow oedema alone, resulting in a sensitivity 
of 38% when compared with   biopsy findings. This study 
did not explore a potential incremental contribution 
of structural SIJ lesions to diagnostic utility. Two other 
studies using physician expert opinion as gold standard 
reported sensitivities of SIJ MRI defined by presence of 
typical bone marrow oedema between ~35% and 42% in 
patients with back pain clinically considered to have early 
axial SpA.20 36 These data substantiate the possibility of 
recognition of axial SpA even in the absence of imaging 
abnormalities, rendering a positive SIJ MRI, an imaging 
biomarker of the disease, but not an independent diag-
nostic test by itself. In clinical practice, normal SIJ MRI 
findings cannot rule out a diagnosis of early axial SpA 
suspected on clinical grounds. Similarly, even in long-
standing established disease in patients with radiographic 
evidence of axial involvement fulfilling the mNY criteria, 
and considered by their rheumatologist as having active 
disease requiring therapeutic escalation, inflammatory 
abnormalities were not found in all patients on MRI of 
the SIJ or spine: 15%–20% of patients with AS included 
in controlled trials of anti-TNF agents had no detectable 
active lesion on their baseline MRI scans.37 38
Integration of structural lesions in the assessment of SIJ MrI
Given these strengths and limitations of MRI in the diag-
nostic approach of patients with inflammatory back pain, 
it has been suggested to explore 'inflammatory' lesions on 
SIJ MRI, and to assess structural changes, which may confer 
additional clinically relevant information by contextual 
lesion interpretation simultaneously on T1-weighted and 
short tau inversion recovery (STIR) sequences.39 Struc-
tural lesions described for decades in AS by radiography 
of the pelvis and more reliably on CT scans, are mainly 
represented by erosion, partial or complete ankylosis of 
SIJ, and sclerosis. Another type of lesion, which cannot 
be seen on radiographic modalities, is fat metaplasia of 
the subchondral bone.
Several studies have been conducted, aiming at evalu-
ating the ability of MRI of SIJ to detect active inflammatory 
lesions (bone marrow oedema), and various structural 
changes, including the key feature erosion. A prelimi-
nary international work based on SIJ MRI assessment by 
five readers (two radiologists and three rheumatologists) 
and a sample size of 187 subjects with either definite AS, 
inflammatory back pain without radiographic evidence 
of AS, non-specific back pain and healthy controls 
without symptoms suggestive of SpA showed that blinded 
and systematic assessment of MRI scans of SIJ had very 
good diagnostic utility for both radiographic and non-ra-
diographic SpA with positive likelihood ratios of 44.6 and 
26.0, respectively. The incorporation of erosion in the 
evaluation of SIJ MRI resulted in an increase in sensitivity 
from 67% to 81%, without affecting specificity with 88% 
in both settings, based on concordant findings by at least 
two out of five independent readers.30 It could also be 
concluded from this exercise that structural lesions can 
occur earlier than expected in the disease course with 
erosion being present in 59.3% of patients with non-ra-
diographic SpA after a mean symptom duration of 29 
months. Fat infiltration as well as bone marrow oedema 
were relatively non-specific, as they were also commonly 
observed in patients with non-specific back pain and 
even in healthy subjects. Actually, although fat infiltra-
tion showed good face validity, data-driven assessment 
of its diagnostic utility revealed disappointing perfor-
mance, mainly due to redundant information conferred 
by simultaneous presence of bone marrow oedema and 
erosive lesions.40 The prevalence of the clinically relevant 
setting of erosive SIJ changes alone without concomitant 
bone marrow oedema in patients with non-radiographic 
SpA—as illustrated in figures 1–4—was comparable in a 
cross-sectional study and in an interventional trial with 
13.0%41 and 10.9%42 patients with a mean symptom dura-
tion of 2.4 years and 2.5 years, respectively
Another study, conducted in patients aged ≤50 years 
with either clinically suspected SpA or with acute ante-
rior uveitis and chronic back pain, aimed at data-driven 
lesion-based definitions of a positive MRI of SIJ. The 
patients were evaluated by clinical examination, pelvic 
radiography and laboratory values (HLA B27 and C reac-
tive protein), which were the basis for a ‘rheumatologist 
expert’ diagnosis serving as gold standard without the 
information obtained from MRI. MRI of SIJ of patients 
with SpA, as well as patients with non-specific back pain 
and healthy subjects, were independently scored by four 
Figure 1 A 38-year-old man, with recurrent inflammatory 
back pain and alternating buttock pain for 2 years. No 
extra-articular manifestations nor family history suggestive 
of spondyloarthritis, moderately raised C-reactive protein 
(CRP) (37 mg/L, reference range <5 mg/L) and erythrocyte 
sedimentation rate (ESR) (33 mm/first hour). HLA B27 
negative. Pelvic radiography shows minimal sclerosis and 
irregularities of the inferior part of the sacroiliac joints, 
especially on the right side (arrow), resulting in an 'equivocal 
finding', that is, insufficient confidence in a diagnosis of 
sacroiliitis.
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blinded readers. The diagnostic utility of several lesions 
of potential interest, as well as their combinations, were 
assessed.43 The performance was optimal when both bone 
marrow oedema and erosion were taken into account, 
outperforming definitions based on bone marrow 
oedema lesions only. Erosion, which was a rare finding in 
controls (mean prevalence of ≥2 erosions in 2.5%–9.8% 
of controls), could be observed again in about 10% of 
patients (7.5%–11.3%) in the absence of active inflam-
matory lesions, making it a potentially relevant contribu-
tion to diagnostic utility due to high specificity.
A recent Danish study conducted in 1020 young patients 
with persistent low back pain provides interesting data 
for the apprehension of the diagnostic performance of 
different lesion types on SIJ MRI. Bone marrow oedema 
was observed in 21% of patients recruited from primary 
care with a high proportion of 42% showing lesions of 
limited extent, which were not associated with any of the 
clinical features of the ASAS criteria, but with older age.44 
By contrast, the scarce finding of erosion in only 7.5% 
of patients with back pain was significantly associated 
with important clinical features of SpA such as presence 
of HLA B27 and response to NSAIDs. These findings 
highlight the limited specificity of ‘inflammatory’ bone 
marrow oedema lesions when applied in patients with 
long-standing back pain in primary care, especially in 
older subjects, conferring a potential risk of excess diag-
nosis of axial SpA when based solely on bone marrow 
oedema of limited extent. On the other hand, the results 
emphasise the crucial importance of contextual inter-
pretation of SIJ MRI and the high specificity of erosion, 
which was not affected by older age.
Whether MRI can be used to reliably identify struc-
tural lesions (erosions, joint space narrowing, sclerosis) 
on SIJ was recently tested against low dose CT scans, 
the latter remaining the reference procedure to assess 
these features.45 Among 110 patients who were investi-
gated in this study by Diekhoff et al, 58 were finally diag-
nosed as having axial SpA (35 with non-radiographic 
axial SpA, 23 with AS), and 52 received other diagnoses 
like osteoarthritis or osteitis condensans. MRI showed 
significantly higher sensitivity and concordance with CT 
scan than conventional pelvic radiography for all lesion 
types, except for sclerosis (the latter with non-significant 
difference).
The increasingly recognised relevance of structural 
lesions has been incorporated in a recent update of the 
ASAS definition of active sacroiliitis on SIJ MRI for clas-
sification of axial SpA.46 It is essential that MRI readers 
simultaneously review sequences designed to identify 
inflammation and structural damage. If an equivocal 
inflammatory bone marrow lesion is present, the decision 
may be influenced by the presence of concomitant struc-
tural damage, especially erosion. However, this recently 
accumulated evidence about how to assess MRI in SpA 
has not yet sufficiently permeated into daily routine due 
Figure 2 MRI, STIR sequence of sacroiliac joints (SIJs): 
minimal localised signal increase on both sides of the 
upper part of the left SIJ (arrows), which does not allow to 
discriminate between inflammation, local mechanical strain 
or vascular signal.
Figure 3 MRI, T1-weighted sequence of sacroiliac joints: 
presence of definite erosion in the ilium on both sides 
(arrows), perifocal fatty lesions of subchondral bone and 
localised sclerosis.
Figure 4 CT scan of sacroiliac joints (SIJs): confirmation of 
erosion of both SIJs and regional sclerosis of subchondral 
bone.
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to a lack of dissemination among both radiologists and 
rheumatologists.47
How to apply in daily practice our expanding research skills 
on SIJ MrI assessment?
If SIJ MRI is taking the lead in daily practice for evalua-
tion of patients with persisting low back pain, the uncrit-
ical application of classification proposals will likely result 
in overcalling a diagnosis of SpA, which entails overtreat-
ment and expansion of healthcare cost. The Danish 
study mentioned above reflects this setting.42 In patients 
with chronic low back pain recruited from primary care 
without previous rheumatological assessment, 21% met 
the MRI classification criteria based on SIJ bone marrow 
oedema alone, but 42% of these lesions were small and of 
questionable clinical relevance as they showed no associa-
tion with clinical SpA features. Revision of an earlier diag-
nosis of axial SpA, based mainly on minor changes on 
SIJ MRI, has become a common experience in the daily 
routine of rheumatologists. However, limited accessibility 
of the axial skeleton to clinical examination renders MRI 
of SIJ a very valuable tool for diagnosis, provided it is 
embedded as one element in a deductive process encom-
passing complementary clinical and paraclinical find-
ings. The diagnostic approach to a multifaceted disorder 
such as SpA requires a process of pattern recognition, 
where a careful differential diagnosis on clinical grounds 
is as relevant as an MRI lesion signature. Diagnostic eval-
uation of SIJ MRI itself should not be based on bone 
marrow oedema alone, in particular if only minor lesions 
are present, but should adopt a contextual approach by 
taking into account structural lesions also, which appear 
early in the disease course and enhance specificity.
Should SIJ MrI supplant pelvic radiography in recognition of 
early axial SpA?
Pelvic radiographs are often performed as one element 
of rheumatological evaluation in the clinical setting of 
suspected early SpA, despite limited evidence whether 
they may enhance confidence in a diagnosis of early axial 
SpA. Cohort studies from secondary and tertiary care 
suggest that about 25%–50% of patients, who are clini-
cally suspected of having axial SpA for less than 9 years, 
show definite radiographic SIJ changes compatible with 
AS.48–50 There is ongoing controversy as to whether SIJ 
MRI due to its superior reliability and ability to depict 
both active and structural lesions should be the preferred 
imaging modality in early disease over the traditional 
approach with pelvic radiographs. The EULAR recom-
mendations for the use of imaging in the diagnosis 
and management of SpA in clinical practice state that 
conventional radiography of SIJ is recommended as the 
first imaging method to diagnose sacroiliitis.51 If the diag-
nosis of axial SpA cannot be established based on clinical 
features and conventional radiography, and axial SpA is 
still suspected, MRI of SIJ is recommended. This state-
ment is supported by the European Society of Musculo-
skeletal Radiology.52
However, several studies applying the radiographic 
mNY criteria in patients with clinically suspected early 
axial SpA consistently showed limited agreement among 
trained readers with k values around 0.5.17 A post hoc 
analysis of pelvic radiographs by trained central readers 
in two interventional trials in non-radiographic axial 
SpA resulted in reclassification of 36% and 37% of the 
patients regarding fulfilment of the radiographic mNY 
criteria,53 54 which raised concerns in a public hearing 
of the Food and Drug Administration in 2013, whether 
radiographic classification is appropriate for clinical 
trials in early axial SpA.55 Furthermore, recent data shed 
doubt on reliability of the radiographic mNY criteria to 
evaluate progression of SIJ damage in patients with early 
axial SpA.23 By contrast, emerging evidence suggests 
superior reliability of MRI over radiography to assess 
sacroiliitis in adult and juvenile patients with clinically 
suspected early axial SpA, both by granular and global 
MRI evaluation.16 20 22
Radiographic assessment of SIJ following the mNY 
criteria derived from patients with advanced structural 
SIJ damage has substantial limitations regarding radi-
ation exposure, reliability and assessment of progres-
sion, and may not be directly applicable to patients 
with back pain clinically suspected to have early axial 
SpA. The advantage of radiography is feasibility, as it is 
readily available and can be performed at low costs and 
minimal time loss. These feasibility issues do not apply 
to the potential alternative SIJ MRI, which has limited 
or no access in many parts of the world. However, a crit-
ical reappraisal of using pelvic radiographs in the clin-
ical setting of suspected early SpA is warranted, and in 
healthcare settings, where SIJ MRI is readily available, 
it may be the preferred imaging modality in early axial 
SpA.
ConCLuSIon
MRI of SIJ is a valuable adjunct tool in the workup of 
patients with back pain suspected to have early axial SpA, 
provided an appropriate clinical evaluation including 
differential diagnostic considerations has been made, 
and the context (age, sports activity, body mass index…) 
at the time of MRI is not associated with an expected 
deterioration of performances/metrological proper-
ties. MRI by itself cannot serve as the gold standard to 
make a diagnosis of early axial SpA due to limitations 
both in sensitivity and specificity, and because even an 
advanced imaging modality cannot capture the entire 
clinical spectrum of the disorder. Diagnosing early SpA 
remains a complex deductive process based on thorough 
clinical and paraclinical assessments. MRI may assist in 
confirming a clinical suspicion of SpA, but cannot replace 
a careful clinical examination and differential diagnostic 
assessment in the pattern recognition process towards a 
diagnosis of axial SpA. The role of pelvic radiography, the 
traditional imaging gold standard in AS, ought to be crit-
ically reappraised for growing concerns about reliability 
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and sensitivity, particularly in the clinically challenging 
setting of suspected early SpA.
Contextual interpretation of structural and active 
MRI lesions simultaneously on T1-weighted and STIR 
sequences is key to enhance diagnostic utility of SIJ MRI. 
In the setting of low grade MRI changes, a diagnosis 
should not be made based on bone marrow lesions alone, 
as this constellation is common in back pain conditions 
not related to SpA and even in healthy subjects. Struc-
tural SIJ lesions are emerging to enhance confidence in 
a diagnosis of SpA, highlighted by the high specificity 
of erosion. Future research into the ‘background noise’ 
of different MRI features in patients with non-specific 
back pain and in healthy individuals with varying axial 
strain and further exploration of potential redundancy 
of various MRI lesions is needed towards a data-driven 
definition of a positive SIJ MRI in SpA.
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